1. Home
  2. SLGL vs VELO Comparison

SLGL vs VELO Comparison

Compare SLGL & VELO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLGL
  • VELO
  • Stock Information
  • Founded
  • SLGL 1997
  • VELO 2014
  • Country
  • SLGL Israel
  • VELO United States
  • Employees
  • SLGL N/A
  • VELO N/A
  • Industry
  • SLGL Biotechnology: Pharmaceutical Preparations
  • VELO Industrial Machinery/Components
  • Sector
  • SLGL Health Care
  • VELO Technology
  • Exchange
  • SLGL Nasdaq
  • VELO Nasdaq
  • Market Cap
  • SLGL 69.1M
  • VELO 62.5M
  • IPO Year
  • SLGL 2018
  • VELO N/A
  • Fundamental
  • Price
  • SLGL $23.98
  • VELO $3.20
  • Analyst Decision
  • SLGL
  • VELO
  • Analyst Count
  • SLGL 0
  • VELO 0
  • Target Price
  • SLGL N/A
  • VELO N/A
  • AVG Volume (30 Days)
  • SLGL 33.1K
  • VELO 1.4M
  • Earning Date
  • SLGL 11-14-2025
  • VELO 11-07-2025
  • Dividend Yield
  • SLGL N/A
  • VELO N/A
  • EPS Growth
  • SLGL N/A
  • VELO N/A
  • EPS
  • SLGL N/A
  • VELO N/A
  • Revenue
  • SLGL $23,931,000.00
  • VELO $43,765,000.00
  • Revenue This Year
  • SLGL N/A
  • VELO $330.48
  • Revenue Next Year
  • SLGL $31.17
  • VELO N/A
  • P/E Ratio
  • SLGL N/A
  • VELO N/A
  • Revenue Growth
  • SLGL 264.86
  • VELO N/A
  • 52 Week Low
  • SLGL $4.01
  • VELO $1.43
  • 52 Week High
  • SLGL $30.00
  • VELO $29.25
  • Technical
  • Relative Strength Index (RSI)
  • SLGL 58.56
  • VELO N/A
  • Support Level
  • SLGL $23.13
  • VELO N/A
  • Resistance Level
  • SLGL $24.85
  • VELO N/A
  • Average True Range (ATR)
  • SLGL 2.36
  • VELO 0.00
  • MACD
  • SLGL -0.43
  • VELO 0.00
  • Stochastic Oscillator
  • SLGL 39.19
  • VELO 0.00

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.

About VELO Velo3D Inc. Common stock

Velo3D Inc provides additive manufacturing (AM), also referred to as three-dimensional printing (3D printing), to deliver breakthroughs in performance, cost, and time in the production of high-value metal parts. The Velo3D intelligent metal additive manufacturing solution is comprised of the Velo3D Flow intelligent print preparation software, the Sapphire production system, and Velo3D Assure, real-time quality assurance software. Its complete manufacturing solution enables clients to build the parts needed, speed their development, and reduce their product costs.

Share on Social Networks: